Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest Expenses (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Interest Expenses for 4 consecutive years, with $5905.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 73712.5% to $5905.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37208.0 through Dec 2025, down 38.5% year-over-year, with the annual reading at $502429.0 for FY2025, 4828.67% up from the prior year.
  • Interest Expenses for Q4 2025 was $5905.0 at bioAffinity Technologies, up from $5358.0 in the prior quarter.
  • The five-year high for Interest Expenses was $896502.0 in Q3 2022, with the low at $8.0 in Q4 2024.
  • Average Interest Expenses over 4 years is $100972.9, with a median of $14697.0 recorded in 2024.
  • The sharpest move saw Interest Expenses plummeted 99.96% in 2024, then skyrocketed 73712.5% in 2025.
  • Over 4 years, Interest Expenses stood at $89290.0 in 2022, then tumbled by 77.57% to $20025.0 in 2023, then tumbled by 99.96% to $8.0 in 2024, then surged by 73712.5% to $5905.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $5905.0, $5358.0, and $10460.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.